Log in to save to my catalogue

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04548018v1

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

About this item

Full title

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2020-12, Vol.383 (23), p.2207-2218

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Colorectal cancer is genetically heterogeneous. Tumors in some patients have defects in mismatch DNA repair. These tumors have a high level of mutations that can lead to immune recognition. In a group of patients with microsatellite-unstable tumors, pembrolizumab led to longer progression-free survival and was less toxic than standard chemotherapy.

Alternative Titles

Full title

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_04548018v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04548018v1

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2017699

How to access this item